Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BE.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BE.4.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BE.4.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BE.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BE.4.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BE.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.4.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BE.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.4.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BE.4.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BE.4.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
GM.2ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
GM.2ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
GM.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GM.2ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
GM.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
GM.2ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
GM.2ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
GM.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GM.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-17500.9South Korea
GM.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
GM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GM.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GM.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
GM.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GM.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
GM.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
GM.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GM.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GM.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
GM.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-2113.71Japan
GM.2ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BQ.1.1.20ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BQ.1.1.20ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BQ.1.1.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.20ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BQ.1.1.20ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BQ.1.1.20ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
BQ.1.1.20ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BQ.1.1.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BQ.1.1.20SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BQ.1.1.20SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BQ.1.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used